QIM
HRTX icon

Quantitative Investment Management’s Heron Therapeutics HRTX Stock Holding History

Quantitative Investment Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-119,451
Closed -$2.81M – 653
2019
Q4 		$2.81M Buy
+119,451
New +$2.64M 0.08% 249
2018
Q2 		– Sell
-143,600
Closed -$3.96M – 819
2018
Q1 		$3.96M Buy
+143,600
New +$3.26M 0.07% 320

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Quantitative Investment Management's HRTX Position: Q1 2020 in Review

Quantitative Investment Management sold out of Heron Therapeutics (HRTX) in Q1 2020, closing a stake of 119,451 shares — an estimated $2.81M sold.

Quantitative Investment Management first reported a position in HRTX in Q1 2018 and held it in 2 quarters. The position peaked at $3.96M in Q1 2018. 193 funds tracked by Wall St. Rank hold HRTX as of Q1 2020.

  • Quantitative Investment Management reported no remaining Heron Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Quantitative Investment Management sold 119,451 Heron Therapeutics shares in Q1 2020, an estimated $2.81M.
  • Quantitative Investment Management first reported a position in Heron Therapeutics in Q1 2018 and held it in 2 quarters.
  • Quantitative Investment Management's Heron Therapeutics position peaked at $3.96M in Q1 2018.
  • 193 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2020.

Based on Quantitative Investment Management's 13F filing for Q1 2020, filed 15 May 2020.